ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1576

Identifying Rheumatoid Arthritis Subtypes Using Synovial Tissue Gene Expression Profiling, Histologic Scoring and Clinical Correlates

Dana E. Orange1, Susan M. Goodman2, Phaedra Agius3, Ryan Cummings4, Kathleen Andersen1, Robert Darnell5, Lionel Ivashkiv2, Alessandra B. Pernis6, Edward F. DiCarlo7, Vivian P. Bykerk8 and Laura T. Donlin9, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Medicine, Hospital for Special Surgery, New York, NY, 3New York Genome Center, New York, NY, 4Hospital for Special Surgery, New York, NY, 5The New York Genome Center, New York, NY, 6David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 7Laboratory Medicine, Hospital for Special Surgery, New York, NY, 8Divison of Rheumatology, Hospital for Special Surgery, New York, NY, 9Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: histopathologic, rheumatoid arthritis (RA) and synovial cells, RNA, synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The histopathologic features of synovial tissue vary widely among patients with rheumatoid arthritis (RA) undergoing arthroplasty and the clinical significance of this variability is unknown. Improved methods for assessing synovial histopathology could help characterize subtypes of RA and predict clinical outcomes.

Methods: 149 RA patients undergoing total hip or knee arthroplasty were enrolled. 130 synovial tissue samples were stained with hematoxylin and eosin and assessed for 20 histologic features such as lymphocytic infiltrates, neutrophils, mucoid change, vascularity, synovial lining hyperplasia, detritus, fibrin, plasma cell inflammation, binucleate plasma cells, germinal centers, Russell bodies, mast cells, giant cells and synovial giant cells. 19 of the synovial samples were disaggregated and their synovicoytes analyzed by RNA sequencing. We used a standard unsupervised hierarchical clustering approach to group samples and genes with similar expression profiles. Using the resultant RNAseq sample clusters, we applied a machine learning algorithm (standard Support Vector Machine) using binarized histology features and a leave-one-out cross-validation approach. The model was able to accurately predict which RNAseq cluster a given sample would most likely belong to, suggesting good harmony between the genomic data and the histology. We then used our histology SVM model derived on the 19 samples to cast cluster predictions on the broader set of 130 synovial samples, for which we had complete histology data but no RNAseq.

Results: Unsupervised hierarchical clustering of 19 synoviocyte samples based on genome-wide RNA expression levels identified 2 well-separated subtypes of synovial tissue composition that distinguished samples based on the level of inflammatory cell presence, and a third subgroup within the low-inflammatory cell subset that suggests further subclassification of RA synovial tissue based on non-immune cell types. Confirming the validity of this approach, histology scoring of lymphocytic infiltrates correlated significantly with the RNAseq clusters containing the highest level of hematopoietic lineage transcripts. Furthermore, clinical features such as ESR and obesity correlated with the subsets defined by the RNAseq analyses. Gene set enrichment analysis of differentially expressed genes between the clusters showed variable levels of immune and stromal cell subsets, noting particular differences in IFNg responses. Application of the histology SVM models to the remaining ~100 samples generated predictions of RA synovial gene expression subtypes, which together with ongoing studies connecting clinical parameters to this model suggest an approach to subclassify the disease with greater specificity.

Conclusion: Gene expression clusters derived from RNAseq were used to train a histology scoring system to distinguish between inflammatory and noninflammatory RA synovial tissue. SVM weights indicate that lymphocytic infiltrates, plasma cells, fibrin and synovial lining hyperplasia are predicted to be associated with inflammatory gene expression, while mast cells, vascularity, detritus and mucoid changes are predicted to associate with non-inflammatory samples.


Disclosure: D. E. Orange, None; S. M. Goodman, None; P. Agius, None; R. Cummings, None; K. Andersen, None; R. Darnell, None; L. Ivashkiv, None; A. B. Pernis, None; E. F. DiCarlo, None; V. P. Bykerk, AbbVie, Bristol-Myers Squibb, Pfizer, Genentech, Regeneron, UCB Pharma, 5,NIAMS-NIH, 2; L. T. Donlin, None.

To cite this abstract in AMA style:

Orange DE, Goodman SM, Agius P, Cummings R, Andersen K, Darnell R, Ivashkiv L, Pernis AB, DiCarlo EF, Bykerk VP, Donlin LT. Identifying Rheumatoid Arthritis Subtypes Using Synovial Tissue Gene Expression Profiling, Histologic Scoring and Clinical Correlates [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/identifying-rheumatoid-arthritis-subtypes-using-synovial-tissue-gene-expression-profiling-histologic-scoring-and-clinical-correlates/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-rheumatoid-arthritis-subtypes-using-synovial-tissue-gene-expression-profiling-histologic-scoring-and-clinical-correlates/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology